Related Experiment Video
Updated: May 14, 2026

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
Published on: July 20, 2022
Surgical treatment of infective endocarditis in patients undergoing chronic hemodialysis
Kentaro Yamane1, Hitoshi Hirose, Linda J Bogar
1Division of Cardiothoracic Surgery, Department of Surgery, Thomas Jefferson University, Philadelphia, PA, USA. kyamane777@yahoo.co.jp
Insights
Surgically treated infective endocarditis (IE) in chronic hemodialysis (HD) patients has poor outcomes. These patients face higher operative mortality and lower survival rates compared to non-HD patients, emphasizing prevention needs.
Area of Science:
- Cardiology
- Nephrology
- Infectious Diseases
Background:
- Infective endocarditis (IE) is a serious complication for patients on chronic hemodialysis (HD).
- Surgical management of IE in this population is challenging, with limited data on outcomes.
Purpose of the Study:
- To characterize surgically managed IE in chronic HD patients.
- To compare outcomes between HD and non-HD patients undergoing IE surgery.
Main Methods:
- A retrospective study of 119 patients who underwent surgery for IE between 1998 and 2011.
- Comparison of perioperative and postoperative outcomes between 16 HD patients and 103 non-HD patients.
- Survival analysis using the Kaplan-Meier method.
Main Results:
- HD patients had higher rates of diabetes, Staphylococcus/Enterococcus infections, and annular reconstruction.
- HD patients experienced increased perioperative intra-aortic balloon pump use, open-chest management, and prolonged ventilation.
- Operative mortality was significantly higher in HD patients (38% vs. 9.7%), with 1-year survival at 34% vs. 82% (p < 0.001).
- Chronic HD was an independent predictor of operative and long-term mortality.
Conclusions:
- Surgical outcomes for IE in chronic HD patients are poor.
- Preventing IE in chronic HD patients is crucial due to high mortality and morbidity.
Background And Aim Of The Study:
Infective endocarditis (IE) is a devastating complication in patients undergoing chronic hemodialysis (HD). The study aim was to reveal the characteristics and outcomes of surgically managed IE in chronic HD patients.
Methods:
Between April 1998 and August 2011, a total of 119 patients underwent surgery to treat IE. Of these patients, 16 were receiving chronic HD preoperatively. A comparison between non-HD patients (n = 103) and HD patients (n = 16) was conducted with regards to perioperative variables and postoperative morbidity and mortality. A survival analysis was performed using the Kaplan-Meier method.
Results:
Preoperatively, a greater proportion of HD patients had diabetes mellitus than did non-HD patients (44% versus 16%, p = 0.015). Staphylococcus spp. (56%) and Enterococcus spp. (25%) were the predominant microorganisms in HD patients, while Staphylococcus spp. (37%) and Streptococcus spp. (21%) were predominant in non-HD patients. The most affected valve position was the aortic valve, followed by the mitral and the tricuspid in both groups. An annular reconstruction was performed in 56% of HD patients and in 30% of non-HD patients (p = 0.039). The HD patients had a higher incidence of perioperative use of intra-aortic balloon pump placement (25% versus 6.9%, p = 0.042), postoperative open-chest management (38% versus 9.8%, p = 0.009), and prolonged ventilation (63% versus 33%, p = 0.025). The operative mortality was 9.7% in non-HD patients and 38% in HD patients (p = 0.008). Survival at one year was 82% in the non-HD group and 34% in the HD group (p < 0.001). Multivariable analysis revealed that chronic HD is an independent predictor of operative and long-term mortality.
Conclusion:
The operative outcome after endocarditis in HD patients remains poor, and the importance of preventing endocarditis in chronic HD patients is further emphasized.
Related Concept Videos
Endocarditis III: Medical Management
Endocarditis IV: Nursing Management
Endocarditis I: Introduction
Hemodialysis I: Introduction
Hemodialysis II: Procedure and Complications
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis